ArticleMaterials (Basel, Switzerland)2024
A Novel Concept of Nano-Enhanced Phase Change Material.
Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In the actual context of growing concerns over sustainability and energy efficiency, Phase Change Materials (PCMs) have gained attention as promising solutions for enhancing energy storage and release efficiency. On another hand, materials based on graphene oxide (GO) have proven antibacterial activity, biocompatibility, efficiency in microbial growth inhibition, and pollutant removal. Integrating nanoparticles into PCMs and creating Nano-Enhanced Phase Change Materials (NEPCMs) have opened new horizons for optimizing the performance of these systems and sustainable development. The key objective of this work is to gain insight into NECPMs, which are used in solar wall systems to enhance solar energy storage. Paraffin RT31 was mixed with Cu nanoparticles, graphene oxide (GO), and Cu-decorated GO (Cu@GO) at loading ratios ranging from 1% to 4% (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.